Thought Leadership
ICON experts frequently present at industry events and author or contribute to industry publications. The following are some recent articles.
- 19 November 2009
Brain Serotonin Transporter Occupancy by Oral Sibutramine Dosed to Steady State
A PET Study Using C-DASB in Healthy Humans
- 19 November 2009
Ten Things You Need to Know About Biomarkers
John L Allinson & Ray Briggs
- 13 November 2009
Perflutren Protein-Type A Microspheres Injectable Suspension, USP Does Not Increase Mortality In Critically Ill Patients-Preliminary Results From A Retrospective Matched Case-Control Study
- 13 November 2009
Reducing Bias In A Retrospective Case- Control Study: An Application of Propensity Score Matching
- 01 November 2009
Different Countries, Different Approaches
Vitor Harada of ICON presents the legal aspects when managing global studies, placing the emphasis on the importance of a risk assesment carried out on a country by country basis.
- 20 October 2009
Cushioning the Blow
Following the withdrawl of a number of products from the market, drug safety leaders have taken part in an industry-wide survey to find out what is needed to ease compliance with new regulations.
- 01 October 2009
10 Years On: CRO Perspectives
Contract Research Organizations have followed different paths and models over the past decade. We asked several of the major CROs about the biggest changes and trends they've seen in their part of the business. Here’s what they had to say. —GYR
- 26 July 2009
Cardiology and Oncology Drug Development and Regulation
Stuart L. Cantor, PhD, Senior Scientist, and Kadriye Ciftci, PhD, Senior Director Drug Delivery, ICON Development Solutions
- 06 July 2009
An Interview with Ted Gastineau
- 01 July 2009
Central Labs Go Global
Robert Scott-Edwards
